Pharmacologic targeting of estrogen receptor in melanoma to enhance antitumor immunity.
Publication
, Conference
Chakraborty, B; Bymerwa, J; Baldi, R; Liu, W; Chang, C-Y; McDonnell, D
Published in: CANCER IMMUNOLOGY RESEARCH
March 1, 2020
Duke Scholars
Published In
CANCER IMMUNOLOGY RESEARCH
EISSN
2326-6074
ISSN
2326-6066
Publication Date
March 1, 2020
Volume
8
Issue
3
Start / End Page
53 / 53
Publisher
AMER ASSOC CANCER RESEARCH
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1112 Oncology and Carcinogenesis
- 1107 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Chakraborty, B., Bymerwa, J., Baldi, R., Liu, W., Chang, C.-Y., & McDonnell, D. (2020). Pharmacologic targeting of estrogen receptor in melanoma to enhance antitumor immunity. In CANCER IMMUNOLOGY RESEARCH (Vol. 8, pp. 53–53). AMER ASSOC CANCER RESEARCH.
Chakraborty, Binita, Jovita Bymerwa, Robert Baldi, Wen Liu, Ching-Yi Chang, and Donald McDonnell. “Pharmacologic targeting of estrogen receptor in melanoma to enhance antitumor immunity.” In CANCER IMMUNOLOGY RESEARCH, 8:53–53. AMER ASSOC CANCER RESEARCH, 2020.
Chakraborty B, Bymerwa J, Baldi R, Liu W, Chang C-Y, McDonnell D. Pharmacologic targeting of estrogen receptor in melanoma to enhance antitumor immunity. In: CANCER IMMUNOLOGY RESEARCH. AMER ASSOC CANCER RESEARCH; 2020. p. 53–53.
Chakraborty, Binita, et al. “Pharmacologic targeting of estrogen receptor in melanoma to enhance antitumor immunity.” CANCER IMMUNOLOGY RESEARCH, vol. 8, no. 3, AMER ASSOC CANCER RESEARCH, 2020, pp. 53–53.
Chakraborty B, Bymerwa J, Baldi R, Liu W, Chang C-Y, McDonnell D. Pharmacologic targeting of estrogen receptor in melanoma to enhance antitumor immunity. CANCER IMMUNOLOGY RESEARCH. AMER ASSOC CANCER RESEARCH; 2020. p. 53–53.
Published In
CANCER IMMUNOLOGY RESEARCH
EISSN
2326-6074
ISSN
2326-6066
Publication Date
March 1, 2020
Volume
8
Issue
3
Start / End Page
53 / 53
Publisher
AMER ASSOC CANCER RESEARCH
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1112 Oncology and Carcinogenesis
- 1107 Immunology